Telix Pharmaceuticals | Stammkapital

Aktienkurs
9.85
Täglich Wechseln
-0.28 -2.76%
Monatlich
-10.54%
Jährlich
-65.99%
Q1 Prognose
9.65




Stammkapital Veränderung Datum
Cochlear AUD 1.18B 19.2M 2024-12
CSL USD 576M 19M 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Medical Developments International AUD 115.01M 9.28M 2024-12
Mesoblast USD 1.28B 127.49M 2025-06
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 253.24M 15.12M 2024-12
Polynovo AUD 191.6M 0 2024-06
PYC Therapeutics AUD 230.58M 0 2024-12
Ramsay Health Care AUD 2.27B 19.6M 2024-12
ResMed USD 145.66M 144.9M 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12


Telix Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.